Sukhtian Faisal Ghiath

EDGAR CIK 0001716033

Outlook Therapeutics, Inc. - OTLK

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Director
Direct Buys
2
$150,002
217,572 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
07/29/2026
07/29/2026
Buy
95,398 @ $1.05
 $99,996 220,972 (75.97%) Direct
05/27/2026
05/27/2026
Buy
122,174 @ $0.41
 $50,006 125,574 (3,593.35%) Direct